2013-05-24@15:27:13 ET
Sector Update: Healthcare (MID)
|
2013-05-24@13:53:50 ET
Bottom 5 Performing Dow Stocks (HPQ, VZ, INTC, CAT, MRK) (F70)
|
2013-05-24@12:43:12 ET
Healthcare Stocks Mostly Lower; Merck Suspends Work on Prospective Parkinson's Drug (MID)
|
2013-05-24@12:38:39 ET
Sector Update: Healthcare (MID)
|
2013-05-24@07:58:15 ET
Merck (MRK) Showing Bullish Technicals With Support At $46.04 (FBM)
|
2013-05-24@07:23:33 ET
Australia Patent: Merck Sharp & Dohme Files Application for 'Piperidinone carboxamide azaindane CGRP receptor antagonists' (ABW)
|
2013-05-24@07:22:00 ET
Australia Patent: Merck Sharp & Dohme Files Application for 'Piperidinone carboxamide indane CGRP receptor antagonists' (ABW)
|
2013-05-24@07:20:56 ET
Australia Patent: Merck Sharp & Dohme, Alectos Therapeutics File Application for 'Selective glycosidase inhibitors and uses thereof' (ABW)
|
2013-05-24@04:47:30 ET
Market Maker Surveillance Report. KMB, MRK, CSCO, DF, LEN, ORCL, Bullishly Biased Price Friction For Thursday, May 23rd 2013 (MTO)
|
2013-05-24@01:42:00 ET
Merck Inks $5 Billion Accelerated Share Repurchase Deal (CLM)
|
2013-05-23@15:49:17 ET
Healthcare Stocks Trimming Losses in Late Trade; Kindred Still Looking for New Top After Analyst Upgrade (MID)
|
2013-05-23@15:44:22 ET
Sector Update: Healthcare (MID)
|
2013-05-23@13:00:27 ET
Healthcare Stocks Mostly Lower; Mannkind Extends Takeover-Fueled Rally To A Second Session (MID)
|
2013-05-23@12:33:35 ET
Sector Update: Healthcare (MID)
|
2013-05-23@11:06:30 ET
AstraZeneca has the Highest Dividend Yield in the Pharmaceuticals Industry (AZN, MRK, LLY) (F70)
|
2013-05-23@07:44:43 ET
ALK's partner Merck announces FDA acceptance of BLA for review of AIT drug (DTM)
|
2013-05-23@07:10:20 ET
Merck Enters into Strategic Deal (ZAX)
|
2013-05-23@04:45:29 ET
FDA panel backs a new sleep drug (KRO)
|
2013-05-23@04:16:22 ET
Market Maker Surveillance Report. MRK, CBL, CSCO, CLWR, QQQ, FB, Highest Net Sell Volume and Negative Price Friction For Wednesday, May 22nd 2013 (MTO)
|
2013-05-23@01:58:54 ET
8-K: Merck & Co. Inc. (EDK)
|
